Kitamura H, Matsumoto M, Nagaki K
Immunology. 1984 Nov;53(3):575-82.
C3-independent immune haemolysis was studied using EAC14oxy2 cells and purified C5, C6, C7, C8 and C9. We have found that EAC14oxy2 cells were lysed by C5-C9 and that haemolysis occurs, even after pretreatment of the cells and the C5-C9 preparation with anti-C3. This indicates that EAC14oxy2 can be lysed by C5-C9 without any participation of C3. In contrast, EAC1 and EAC14 cells are not lysed by C5-C9, suggesting that our C5-C9 preparation lacks activated complement components, such as C3bBb, C5b6 or C(56)a. Based on our study of the haemolysis of EAC14oxy2, we have determined that: (i) EAC14oxy2 cells are lysed by a preparation of C5, C6, C7, C8 and C9, but no lysis occurs when any one of these complement is absent, (ii) for significant haemolysis of EAC14oxy2, a higher concentration of C5 is necessary as compared to the C5 requirement when haemolysis occurs in the presence of C3, (iii) the degree of haemolysis is linearly related to the concentration of C5 and does not reach a plateau, despite the addition of as much as 3,200 U of C5, and (iv) the degree of haemolysis is linearly related to the concentration of cell bound C42. These observations suggest that, in the absence of C3, the C3 convertase C42 can activate C5 directly, resulting in the formation of the membrane attack complex, C5b-9.
使用EAC14oxy2细胞以及纯化的C5、C6、C7、C8和C9研究了不依赖C3的免疫溶血作用。我们发现EAC14oxy2细胞可被C5 - C9溶解,并且即使在用抗C3对细胞和C5 - C9制剂进行预处理后,溶血仍会发生。这表明EAC14oxy2可被C5 - C9溶解,而无需C3的任何参与。相比之下,EAC1和EAC14细胞不会被C5 - C9溶解,这表明我们的C5 - C9制剂缺乏活化的补体成分,如C3bBb、C5b6或C(56)a。基于我们对EAC14oxy2溶血作用的研究,我们确定:(i) EAC14oxy2细胞可被C5、C6、C7、C8和C9的制剂溶解,但当这些补体中的任何一种缺失时则不会发生溶解;(ii) 与在C3存在下发生溶血时对C5的需求相比,EAC14oxy2发生显著溶血需要更高浓度的C5;(iii) 溶血程度与C5浓度呈线性关系,并且即使加入多达3200 U的C5也不会达到平台期;(iv) 溶血程度与细胞结合的C42浓度呈线性关系。这些观察结果表明,在没有C3的情况下,C3转化酶C42可直接激活C5,从而导致膜攻击复合物C5b - 9的形成。